...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
【24h】

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)

机译:热休克蛋白70和肿瘤浸润的NK细胞作为预后鳞状细胞癌患者的预后指标:放射性化学治疗后的头部和颈部:德国癌症联盟肿瘤肿瘤学群的多期回顾性研究(DKTK-ROG)

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor cells frequently overexpress heat shock protein 70 (Hsp70) and present it on their cell surface, where it can be recognized by pre‐activated NK cells. In our retrospective study the expression of Hsp70 was determined in relation to tumor‐infiltrating CD56 + NK cells in formalin‐fixed paraffin embedded (FFPE) tumor specimens of patients with SCCHN ( N ?=?145) as potential indicators for survival and disease recurrence. All patients received radical surgery and postoperative cisplatin‐based radiochemotherapy (RCT). In general, Hsp70 expression was stronger, but with variable intensities, in tumor compared to normal tissues. Patients with high Hsp70 expressing tumors (scores 3–4) showed significantly decreased overall survival (OS; p ?=?0.008), local progression‐free survival (LPFS; p ?=?0.034) and distant metastases‐free survival (DMFS; p ?=?0.044), compared to those with low Hsp70 expression (scores 0–2), which remained significant after adjustment for relevant prognostic variables. The adverse prognostic value of a high Hsp70 expression for OS was also observed in patient cohorts with p16‐ ( p ?=?0.001), p53‐ ( p ?=?0.0003) and HPV16 DNA‐negative ( p ?=?0.001) tumors. The absence or low numbers of tumor‐infiltrating CD56 + NK cells also correlated with significantly decreased OS ( p ?=?0.0001), LPFS ( p ?=?0.0009) and DMFS ( p ?=?0.0001). A high Hsp70 expression and low numbers of tumor‐infiltrating NK cells have the highest negative predictive value ( p ?=?0.00004). In summary, a strong Hsp70 expression and low numbers of tumor‐infiltrating NK cells correlate with unfavorable outcome following surgery and RCT in patients with SCCHN, and thus serve as negative prognostic markers.
机译:肿瘤细胞经常过表达热休克蛋白70(HSP70)并将其呈现在其细胞表面上,在那里可以通过预活化的NK细胞识别。在我们的回顾性研究中,HSP70的表达是关于甲醛固定的石蜡嵌入式(FFPE)患者患者的肿瘤浸润的CD56 + NK细胞(N?=?145)作为存活和疾病复发的潜在指标。所有患者都接受了自由基手术和术后顺铂的放射性化学疗法(RCT)。通常,HSP70表达较强,但具有可变强度,与正常组织相比肿瘤。高HSP70表达肿瘤的患者(分数3-4)显示出显着降低总存活(OS; P?= 0.008),局部进展生存期(LPFS; P?= 0.034)和远处转移存活(DMFS;与具有低HSP70表达(分数0-2)的那些相比,P?= 0.044),其在调整相关预后变量后保持显着。在P16-(P≤= 0.001)的患者群组中也观察到OS的高HSP70表达的不良预后值,p53-(p?= 0.0003)和HPV16 DNA阴性(P?= 0.001)肿瘤。肿瘤浸润CD56 + NK细胞的缺失或少量也与显着降低的OS(p?= 0.0001),LPF(P?= 0.0009)和DMFS(P?= 0.0001)相关。高HSP70表达和少量肿瘤渗透NK细胞具有最高的负预测值(P?= 0.00004)。总之,强HSP70表达和少量肿瘤渗透NK细胞与SCCHN患者手术和RCT后的不利结果相关,因此用作负预后标志物。

著录项

  • 来源
  • 作者单位

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    MVZ Radiologie und Strahlentherapie NürnbergNürnberg Germany;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

    Institute of Medical Informatics Statistics and Epidemiology Technische Universit?t München (TUM;

    Department of Radiotherapy and OncologyGoethe University FrankfurtGermany;

    Department of Radiotherapy and OncologyGoethe University FrankfurtGermany;

    Department of Radiotherapy and OncologyGoethe University FrankfurtGermany;

    Department of Radiotherapy and OncologyGoethe University FrankfurtGermany;

    OncoRay – National Centre for Radiation Research in Oncology Faculty of Medicine and University;

    OncoRay – National Centre for Radiation Research in Oncology Faculty of Medicine and University;

    OncoRay – National Centre for Radiation Research in Oncology Faculty of Medicine and University;

    OncoRay – National Centre for Radiation Research in Oncology Faculty of Medicine and University;

    Department of Radiooncology and RadiotherapyCharite University Hospital BerlinBerlin Germany;

    Department of Radiooncology and RadiotherapyCharite University Hospital BerlinBerlin Germany;

    Department of Radiotherapy Medical FacultyUniversity of Duisburg‐EssenEssen Germany;

    Department of Radiation Oncology Medical FacultyMedical Centre University of FreiburgGermany;

    German Cancer Research Centre (DKFZ) Heidelberg and German Research Consortium (DKTK);

    German Cancer Research Centre (DKFZ) Heidelberg and German Research Consortium (DKTK);

    German Cancer Research Centre (DKFZ) Heidelberg and German Research Consortium (DKTK);

    German Cancer Research Centre (DKFZ) Heidelberg and German Research Consortium (DKTK);

    Department of Radiation OncologyFaculty of Medicine and University Hospital Tübingen Eberhard;

    Department of Radiation OncologyFaculty of Medicine and University Hospital Tübingen Eberhard;

    Department of Radiation OncologyKlinikum rechts der Isar Technische Universit?t München (TUM;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Hsp70; prognostic biomarker; SCCHN; NK cells; IHC; retrospective trial;

    机译:HSP70;预后生物标志物;SCCHN;NK细胞;IHC;回顾性试验;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号